<DOC>
	<DOCNO>NCT00639366</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . It yet know whether radiation therapy direct head effective preventing brain metastases patient advanced cancer . PURPOSE : This randomized phase III trial study radiation therapy head see well work prevent brain metastasis woman receive trastuzumab chemotherapy metastatic locally advanced breast cancer .</brief_summary>
	<brief_title>Radiation Therapy Head Preventing Brain Metastases Women Receiving Trastuzumab Chemotherapy Metastatic Locally Advanced Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To test prophylactic cranial radiotherapy deliver 30 Gy 10 fraction significantly reduce ( 35 % 21 % 2 year ) incidence symptomatic brain metastasis patient treat trastuzumab ( Herceptin® ) metastatic breast cancer . OUTLINE : This multicenter study . Patients stratify center , type systemic therapy ( trastuzumab [ Herceptin® ] monotherapy v combination chemotherapy ) , hormone receptor status , presence lung metastasis ( yes v ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive taxane/trastuzumab therapy 6 week . While continue taxane/trastuzumab therapy , patient undergo 10 fraction concurrent prophylactic cranial radiotherapy absence disease progression unacceptable toxicity . - Arm II : Patients receive taxane/trastuzumab therapy without concurrent prophylactic cranial radiotherapy . All patient undergo quality life assessment every 8 week 9 month . After completion study treatment , patient follow periodically least 1 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven breast carcinoma Metastatic locally advance disease Must demonstrate HER2 3+ positivity IHC 2+ overexpression FISH test demonstrate CerB2 gene amplification No known suspect brain metastasis CNS disease , define presence follow key symptom : Headache Nausea and/or vomit Clinical sign raise intracranial pressure Seizures Focal symptom Cognitive dysfunction Affective disorder Hormone receptor status specify PATIENT CHARACTERISTICS : Female Postmenopausal status specify ECOG performance status 0 1 Patients must apriori suitable trastuzumab ( Herceptin® ) +/ chemotherapy term bone marrow , hepatic , renal function No prior history cerebrovascular disease neurological disorder include seizure PRIOR CONCURRENT THERAPY : No prior cranial radiotherapy No prior neurosurgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>